Company: SHPH
Filing Date: 2025-04-10
Form Type: PRER14A
Source: 0001641172-25-003635
Chunk: 12

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-04-10
Form: PRER14A
Chunk 12
---
 depth and breadth of business experience or other background characteristics, his or her independence and the needs of the Board of Directors. All members of the Nominating and Corporate Governance Committee are independent directors. A copy of our Nominating and Corporate Governance Committee Charter is located under the “Investor Relations-Governance” tab on our website at www.shuttlepharma.com.

Audit Committee

| MEMBERS                    |     | MEETINGS               
 HELD IN 2024: 5*       
 ACTIONS                
 BY WRITTEN CONSENT: 2* |
| Steve                      
 Richards, MBA, CPA (Chair) |     |                        |
| George                     
 Scorsis                    |     |                        |
| Oleh                       
 Nabyt                      |     |                        |

The Audit Committee of our Board of Directors is our standing audit committee established in accordance with Section 3(a)(58)(A) of the Exchange Act.

* Messrs. Scorsis and Nabyt joined as the Company’s Board in February 2025. Accordingly, our previous Audit Committee members participated in the Audit Committee meetings held in 2024, or took action by written consent in 2024, until their resignations in February 2025.

| 8 |

KEY RESPONSIBILITIES

| ● | Reviews                                                                                                                               
 and discusses the financial statements for the financial year ended.                                                                  |
|:--|:--------------------------------------------------------------------------------------------------------------------------------------|
| ● | Oversees                                                                                                                              
 the accounting and financial reporting processes of the Company and the audits of the financial statements of the Company.            |
| ● | Discusses                                                                                                                             
 with the Company’s independent accountants the matters required to be discussed by the statement on Auditing Standards No.            
 61, as amended.                                                                                                                       |
| ● | Reviews                                                                                                                               
 written disclosures and letters from the independent accountant required by applicable requirements of the Public Company Accounting  
 Oversight Board, or the PCAOB, regarding the independent accountant’s communications with the Audit Committee concerning independence 
 and discusses with the independent accountant the independent accountant’s independence.                                              |
| ● | Based                                                                                                                                 
 on the review and discussions with the Company’s independent accountant, recommends to the Board of Directors that such audited       
 financial statements and unaudited interim financial statements be included in the Company’s annual report on Form 10–K               
 and quarterly reports on Form 10-Q, respectively, for the applicable periods for filing with the SEC.                                 |

COMPENSATION Committee

| MEMBERS         |     | MEETINGS               
 HELD IN 202